An ER-Horse Detonating Stress Cascade for Hepatocellular Carcinoma Nanotherapy.
An ER-Horse Detonating Stress Cascade for Hepatocellular Carcinoma Nanotherapy.
复制标题
DOI:
10.1021/acsnano.2c11922
复制
发表时间:
2023-02
期刊:
影响因子:
17.1
通讯作者:
X. Bian;Ningke Fan;Meng Li;Daobin Han;Jia Li;Lu Fan;Xinyu Li;Liangsheng Kong;Hua Tang;Shi-jia Ding;Fangzhou Song;Siqiao Li;W. Cheng
中科院分区:
文献类型:
--
作者:
X. Bian;Ningke Fan;Meng Li;Daobin Han;Jia Li;Lu Fan;Xinyu Li;Liangsheng Kong;Hua Tang;Shi-jia Ding;Fangzhou Song;Siqiao Li;W. Cheng
Persisting and excessive endoplasmic reticulum stress (ERS) can evoke rapid cell apoptosis. Therapeutic interference of ERS signaling holds enormous potential for cancer nanotherapy. Herein, a hepatocellular carcinoma (HCC) cell-derived ER vesicle (ERV) encapsulating siGRP94, denoted as ER-horse, has been developed for precise HCC nanotherapy. Briefly, ER-horse, like the Trojan horse, was recognized via homotypic camouflage, imitated the physiological function of ER, and exogenously opened the Ca2+ channel. Consequently, the mandatory pouring-in of extracellular Ca2+ triggered the aggravated stress cascade (ERS and oxidative stress) and apoptosis pathway with the inhibition of unfolded protein response by siGRP94. Collectively, our findings provide a paradigm for potent HCC nanotherapy via ERS signaling interference and exploring therapeutic interference of physiological signal transduction pathways for precision cancer therapy.